Mackenzie Financial
ASND icon

Mackenzie Financial’s Ascendis Pharma A/S ASND Stock Holding History

Mackenzie Financial’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,319
Closed -$725K – 1582
2024
Q2 		$725K Sell
5,319
-208
-4% -$28.3K ﹤0.01% 926
2024
Q1 		$836K Buy
5,527
+1,072
+24% +$153K ﹤0.01% 919
2023
Q4 		$561K Sell
4,455
-198
-4% -$19.7K ﹤0.01% 968
2023
Q3 		$409K Sell
4,653
-353
-7% -$33K ﹤0.01% 1051
2023
Q2 		$441K Sell
5,006
-939
-16% -$81.7K ﹤0.01% 1055
2023
Q1 		$637K Sell
5,945
-467
-7% -$53.4K ﹤0.01% 955
2022
Q4 		$783K Buy
6,412
+733
+13% +$85.1K ﹤0.01% 812
2022
Q3 		$586K Buy
5,679
+1,384
+32% +$131K ﹤0.01% 898
2022
Q2 		$399K Buy
4,295
+1,393
+48% +$131K ﹤0.01% 991
2022
Q1 		$341K Sell
2,902
-5,124
-64% -$593K ﹤0.01% 1070
2021
Q4 		$1.08M Sell
8,026
-509
-6% -$75.7K ﹤0.01% 894
2021
Q3 		$1.36M Sell
8,535
-455
-5% -$62.3K ﹤0.01% 837
2021
Q2 		$1.18M Sell
8,990
-670
-7% -$89.3K ﹤0.01% 828
2021
Q1 		$1.25M Buy
9,660
+610
+7% +$92.7K ﹤0.01% 779
2020
Q4 		$1.51M Buy
9,050
+438
+5% +$72.4K ﹤0.01% 656
2020
Q3 		$1.33M Buy
8,612
+783
+10% +$113K ﹤0.01% 626
2020
Q2 		$1.16M Sell
7,829
-224
-3% -$30.8K ﹤0.01% 651
2020
Q1 		$907K Sell
8,053
-249
-3% -$32.4K ﹤0.01% 667
2019
Q4 		$1.16M Sell
8,302
-520
-6% -$57.8K ﹤0.01% 708
2019
Q3 		$850K Buy
8,822
+1,253
+17% +$140K ﹤0.01% 745
2019
Q2 		$872K Buy
+7,569
New +$906K ﹤0.01% 771

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mackenzie Financial's ASND Position: Q3 2024 in Review

Mackenzie Financial sold out of Ascendis Pharma A/S (ASND) in Q3 2024, closing a stake of 5,319 shares — an estimated $725K sold.

Mackenzie Financial first reported a position in ASND in Q2 2019 and held it in 21 quarters. The position peaked at $1.51M in Q4 2020. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

  • Mackenzie Financial reported no remaining Ascendis Pharma A/S position as of Q3 2024 after selling out during the quarter.
  • Mackenzie Financial sold 5,319 Ascendis Pharma A/S shares in Q3 2024, an estimated $725K.
  • Mackenzie Financial first reported a position in Ascendis Pharma A/S in Q2 2019 and held it in 21 quarters.
  • Mackenzie Financial's Ascendis Pharma A/S position peaked at $1.51M in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Mackenzie Financial's 13F filing for Q3 2024, filed 13 Nov 2024.